NDRA
ENDRA Life Sciences Inc. (NDRA) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
NDRA’s disclosed environmental profile appears limited versus larger medtech peers, which constrains comparability and keeps its positioning only moderate on available evidence.
Zero reported R&D intensity in the provided metrics suggests a lighter innovation footprint than peers, but it does not by itself indicate superior environmental management.
Low leverage reduces balance-sheet pressure that can otherwise delay environmental investments, yet peer-relative environmental disclosure remains too sparse to support a stronger score.
No material environmental controversies were provided, but the absence of detailed emissions, waste, or resource-use data leaves NDRA behind peers with fuller ESG reporting.
Social
NDRA’s social positioning is constrained by limited public metrics, which weakens peer comparability even if no major labor or product-safety issues were provided.
The absence of disclosed stock-based compensation in the supplied data may indicate lower internal dilution pressure, but it is not a direct social advantage versus peers.
As a medical-device company, product responsibility and patient safety are material, yet no filing-based evidence was provided to show stronger controls than peers.
Sparse disclosure on workforce practices, diversity, and community impact keeps NDRA in the middle of the peer set rather than among stronger social reporters.
Governance
NDRA’s low debt-to-equity ratio suggests conservative capital structure discipline, which can reduce creditor pressure and support cleaner governance than more levered peers.
Net debt to EBITDA is also low in the provided metrics, indicating limited balance-sheet risk and fewer governance constraints tied to refinancing or covenant stress.
However, the available data do not show board independence, audit quality, or shareholder-rights practices, so governance strength cannot be ranked above peers with fuller disclosure.
Zero stock-based compensation in the supplied metrics may reduce incentive complexity, but the lack of broader governance evidence keeps the score in the moderate range.
Overall Score
NDRA ranks as a moderate ESG performer versus peers because conservative leverage is a relative strength, but sparse disclosure limits evidence of broader environmental, social, and governance leadership.
Score Driver: Limited ESG Disclosure Versus Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on ENDRA Life Sciences Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
